WHO approves antibody treatment for some COVID-19 patients
CA, 25 Sep 2021
Regeneron, an expensive monoclonal antibody cocktail, has been approved by the World Health Organization for high risk COVID-19 patients.
The supply of the treatment is low in Canada and while more is on its way, Regeneron is rarely offered due to its price tag.
But as Jamie Mauracher explains, one COVID-19 survivor says she would have done anything for a treatment that could have prevented her pain.
For more info, please go to https://globalnews.ca/news/8218172/canada-regeneron-monoclonal-antibody-covid-treatment/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
The supply of the treatment is low in Canada and while more is on its way, Regeneron is rarely offered due to its price tag.
But as Jamie Mauracher explains, one COVID-19 survivor says she would have done anything for a treatment that could have prevented her pain.
For more info, please go to https://globalnews.ca/news/8218172/canada-regeneron-monoclonal-antibody-covid-treatment/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
